BONGIOVANNI, LAURA
BONGIOVANNI, LAURA
E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis
2020 Silvestri, S.; Porcellato, I.; Mechelli, L.; Menchetti, L.; Iussich, S.; De Maria, R.; Sforna, M.; Bongiovanni, L.; Brachelente, C.
Editorial: Canine melanoma in comparative oncology: Translate research advances to develop new diagnostic and therapeutic options
2022 Bongiovanni, Laura; Brachelente, Chiara; Dow, Steven; Bergman, Philip J
H2AFZ: a novel prognostic marker in canine melanoma and a predictive marker for resistance to CDK4/6 inhibitor treatment
2021 Bongiovanni, Laura; Andriessen, Anneloes; Silvestri, Serenella; Porcellato, Ilaria; Brachelente, Chiara; de Bruin, Alain
Survivin and Sox9: Potential Stem Cell Markers in Canine Normal, Hyperplastic, and Neoplastic Canine Prostate
2019 Bongiovanni, Laura; Caposano, Francesca; Romanucci, Mariarita; Grieco, Valeria; Malatesta, Daniela; Brachelente, Chiara; Massimini, Marcella; Benazzi, Cinzia; Thomas, Rachel E.; Salda, Leonardo Della
Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle
2017 Brachelente, Chiara; Cappelli, Katia; Capomaccio, Stefano; Porcellato, Ilaria; Silvestri, Serenella; Bongiovanni, Laura; De Maria, Raffaella; VERINI SUPPLIZI, Andrea; Mechelli, Luca; Sforna, Monica
Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3+ and CD20+ lymphocytic populations
2020 Porcellato, I.; Silvestri, S.; Menchetti, L.; Recupero, F.; Mechelli, L.; Sforna, M.; Iussich, S.; Bongiovanni, L.; Lepri, E.; Brachelente, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis | 2020 | Silvestri, S.; Porcellato, I.; Mechelli, L.; Menchetti, L.; Iussich, S.; De Maria, R.; Sforna, M.; Bongiovanni, L.; Brachelente, C. | |
| Editorial: Canine melanoma in comparative oncology: Translate research advances to develop new diagnostic and therapeutic options | 2022 | Bongiovanni, Laura; Brachelente, Chiara; Dow, Steven; Bergman, Philip J | |
| H2AFZ: a novel prognostic marker in canine melanoma and a predictive marker for resistance to CDK4/6 inhibitor treatment | 2021 | Bongiovanni, Laura; Andriessen, Anneloes; Silvestri, Serenella; Porcellato, Ilaria; Brachelente, Chiara; de Bruin, Alain | |
| Survivin and Sox9: Potential Stem Cell Markers in Canine Normal, Hyperplastic, and Neoplastic Canine Prostate | 2019 | Bongiovanni, Laura; Caposano, Francesca; Romanucci, Mariarita; Grieco, Valeria; Malatesta, Daniela; Brachelente, Chiara; Massimini, Marcella; Benazzi, Cinzia; Thomas, Rachel E.; Salda, Leonardo Della | |
| Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle | 2017 | Brachelente, Chiara; Cappelli, Katia; Capomaccio, Stefano; Porcellato, Ilaria; Silvestri, Serenella; Bongiovanni, Laura; De Maria, Raffaella; VERINI SUPPLIZI, Andrea; Mechelli, Luca; Sforna, Monica | |
| Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3+ and CD20+ lymphocytic populations | 2020 | Porcellato, I.; Silvestri, S.; Menchetti, L.; Recupero, F.; Mechelli, L.; Sforna, M.; Iussich, S.; Bongiovanni, L.; Lepri, E.; Brachelente, C. |